123 related articles for article (PubMed ID: 38561143)
1. Bedaquiline susceptibility testing of Mycobacterium abscessus complex and Mycobacterium avium complex: A meta-analysis study.
Wang M; Men P; Zhang W; Wu J; Gu Y; Wang F; Huang H; Yu X; Duan H
J Glob Antimicrob Resist; 2024 Jun; 37():135-140. PubMed ID: 38561143
[TBL] [Abstract][Full Text] [Related]
2. Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study.
Hajikhani B; Nasiri MJ; Hosseini SS; Khalili F; Karimi-Yazdi M; Hematian A; Nojookambari NY; Goudarzi M; Dadashi M; Mirsaeidi M
J Glob Antimicrob Resist; 2021 Sep; 26():188-193. PubMed ID: 34153525
[TBL] [Abstract][Full Text] [Related]
3.
Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
[No Abstract] [Full Text] [Related]
4. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
[TBL] [Abstract][Full Text] [Related]
5. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
6. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
7.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
8. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.
Kim SY; Jhun BW; Moon SM; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Diagn Microbiol Infect Dis; 2019 May; 94(1):38-40. PubMed ID: 30581010
[TBL] [Abstract][Full Text] [Related]
9. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
10.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
11. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients.
Gao J; Pei Y; Yan X; Shi G; Li T; Gao M; Liu Y; Wang Y; Shu W; Li L; Pang Y
Int J Infect Dis; 2020 Nov; 100():196-198. PubMed ID: 32890726
[TBL] [Abstract][Full Text] [Related]
12. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.
Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T;
Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087
[TBL] [Abstract][Full Text] [Related]
13. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
[TBL] [Abstract][Full Text] [Related]
14. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
15. TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
Sarathy JP; Ganapathy US; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964791
[TBL] [Abstract][Full Text] [Related]
16. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
17. Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.
Kim SY; Kim DH; Moon SM; Song JY; Huh HJ; Lee NY; Shin SJ; Koh WJ; Jhun BW
Sci Rep; 2021 Mar; 11(1):6108. PubMed ID: 33731862
[TBL] [Abstract][Full Text] [Related]
18.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria.
Martin A; Godino IT; Aguilar-Ayala DA; Mathys V; Lounis N; Villalobos HR
J Med Microbiol; 2019 Aug; 68(8):1137-1139. PubMed ID: 31210631
[TBL] [Abstract][Full Text] [Related]
20. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
